天堂国产午夜亚洲专区-少妇人妻综合久久蜜臀-国产成人户外露出视频在线-国产91传媒一区二区三区

當(dāng)前位置:主頁(yè) > 醫(yī)學(xué)論文 > 外科論文 >

經(jīng)部分椎弓根入路經(jīng)皮內(nèi)鏡治療高度向下游離型腰椎間盤突出癥

發(fā)布時(shí)間:2018-08-22 18:56
【摘要】:目的:探討經(jīng)皮內(nèi)鏡下通過(guò)部分椎弓根入路,治療高度向下游離型腰椎間盤突出癥的可行性和安全性,觀察臨床治療效果。方法:選擇2014年7月至2016年1月我院收治的共21例高度向下游離型腰椎間盤突出癥患者(其中L3/4 3例,L4/5 15例,L5/S1 3例),保守治療3周效果不佳。經(jīng)皮脊柱內(nèi)鏡下,磨除部分椎弓根,摘除高度游離的椎間盤髓核組織,解除神經(jīng)根壓迫。統(tǒng)計(jì)手術(shù)時(shí)間和手術(shù)相關(guān)并發(fā)癥。通過(guò)術(shù)前和術(shù)后視覺(jué)模擬評(píng)分(Visual analog scale,VAS)評(píng)分、功能障礙指數(shù)(Oswestry disability index,ODI)評(píng)估患者術(shù)后改善情況,使用改良Macnab療效評(píng)定標(biāo)準(zhǔn)評(píng)估手術(shù)療效。結(jié)果:所有患者均成功實(shí)施手術(shù),手術(shù)時(shí)間93±10min。1例患者術(shù)后第1天出現(xiàn)下肢神經(jīng)感覺(jué)異常,經(jīng)保守治療后癥狀緩解;無(wú)感染、神經(jīng)血管損傷、硬脊膜撕裂等并發(fā)癥出現(xiàn)。隨訪12個(gè)月,VAS術(shù)前7.57±1.09分,術(shù)后1天2.90±0.52分,術(shù)后1月2.24±0.52分,術(shù)后3月1.86±0.63分,術(shù)后6月1.38±0.48分,術(shù)后12月1.19±0.49分,與術(shù)前比較均有顯著性差異(p0.01);ODI評(píng)分由術(shù)前(54.86±12.67)%減少到術(shù)后12月時(shí)(11.80±1.73)%,與術(shù)前比較均有顯著性差異(p0.01)。根據(jù)改良Macnab評(píng)估標(biāo)準(zhǔn),術(shù)后12月時(shí)優(yōu)15例,良4例,可2例,差0例,術(shù)后優(yōu)良率為90.47%。結(jié)論:經(jīng)部分椎弓根入路經(jīng)皮內(nèi)鏡下腰椎間盤切除術(shù)治療高度向下游離型椎間盤突出癥是一種安全、可行、有效的治療方法。
[Abstract]:Objective: to investigate the feasibility and safety of percutaneous endoscopic approach for the treatment of highly downstream lumbar disc herniation through partial pedicle approach. Methods: from July 2014 to January 2016, 21 patients with highly downstream protrusion of lumbar intervertebral disc (L3 / 43, L4 / 5 / 515, L5 / S1, 3 cases) were treated in our hospital. The results of conservative treatment for 3 weeks were not good. Under percutaneous spinal endoscopy, partial pedicle was removed, nucleus pulposus tissue was removed and nerve root compression was relieved. The time of operation and the complications associated with the operation were calculated. Preoperative and postoperative visual analogue score (Visual analog scale( Visual analog), dysfunction index (Oswestry disability) were used to evaluate the postoperative improvement, and modified Macnab evaluation criteria were used to evaluate the outcome of the operation. Results: all the patients were successfully operated. The operation time was 93 鹵10min.1, the first day after operation, the lower extremity nerve sensation was abnormal, the symptoms were relieved after conservative treatment, no infection, nerve and blood vessel injury, dural tear and other complications occurred. VAS was followed up for 12 months (7.57 鹵1.09, 2.90 鹵0.52, 2.24 鹵0.52, 1.86 鹵0.63, 1.38 鹵0.48 and 1.19 鹵0.49, respectively). The ODI scores decreased from (54.86 鹵12.67)% to (11.80 鹵1.73) 12 months after operation (p0.01). According to the modified Macnab evaluation criteria, 15 cases were excellent at 12 months after operation, 4 cases were good, 2 cases were fair, and 0 cases were poor. The excellent and good rate was 90.47%. Conclusion: percutaneous endoscopic lumbar discectomy via partial pedicle approach is a safe, feasible and effective method for the treatment of highly downstream disc herniation.
【學(xué)位授予單位】:重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R687.3

【參考文獻(xiàn)】

相關(guān)期刊論文 前7條

1 張西峰;張琳;;脊柱內(nèi)鏡技術(shù)的歷史、現(xiàn)狀與發(fā)展[J];中國(guó)疼痛醫(yī)學(xué)雜志;2015年02期

2 陳果;曾建成;宋躍明;孔清泉;聶鴻飛;王賢帝;李柱海;蔣虎山;裴福興;;經(jīng)皮內(nèi)鏡椎板間入路微創(chuàng)治療腋下型L_5S_1椎間盤突出癥[J];中國(guó)矯形外科雜志;2014年13期

3 薛祥云;左小華;趙紅霞;張前西;王茜;陳波濤;馬柯;劉延青;;TESSYS椎間孔鏡技術(shù)在腰椎間盤突出癥中治療技巧探討[J];中國(guó)疼痛醫(yī)學(xué)雜志;2014年06期

4 石磊;楚磊;陳亮;柯珍勇;陳富;程昀;徐洲;程思;晏錚劍;鄧忠良;;經(jīng)皮對(duì)側(cè)椎間孔入路內(nèi)窺鏡下椎間盤切除術(shù)治療游離型腰椎間盤突出癥[J];中國(guó)脊柱脊髓雜志;2014年05期

5 李振宙;侯樹勛;宋科冉;商衛(wèi)林;吳聞文;;經(jīng)椎板間隙入路完全內(nèi)窺鏡下椎間盤摘除術(shù)治療L5/S1非包含型椎間盤突出癥[J];中國(guó)脊柱脊髓雜志;2013年09期

6 周躍;;正確認(rèn)識(shí)經(jīng)皮椎間孔鏡技術(shù)[J];中國(guó)骨與關(guān)節(jié)雜志;2013年04期

7 鄭文杰;周躍;李長(zhǎng)青;;經(jīng)皮椎間孔鏡技術(shù)治療腰椎間盤突出癥的策略和方法[J];中國(guó)骨與關(guān)節(jié)雜志;2013年04期

,

本文編號(hào):2198009

資料下載
論文發(fā)表

本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2198009.html


Copyright(c)文論論文網(wǎng)All Rights Reserved | 網(wǎng)站地圖 |

版權(quán)申明:資料由用戶fd9fe***提供,本站僅收錄摘要或目錄,作者需要?jiǎng)h除請(qǐng)E-mail郵箱bigeng88@qq.com